ferumoxytol

This page shows the latest ferumoxytol news and features for those working in and with pharma, biotech and healthcare.

Amag buys into maternal health business

Adding Makena into its portfolio will give Amag an opportunity in future to increase sales of its own flagship product Feraheme (ferumoxytol), used to treat iron-deficiency anaemia in patients with

Latest news

Death leads to recall of batch of Takeda's Rienso in Switzerland

Marketing partner Amag also reports three other hypersensitivity reactions. Takeda has recalled a batch of its anaemia medicine Rienso (ferumoxytol) in Switzerland following four reports of hypersensitivity reactions, including one death.
SMC approves Eliquis, restricts use of Rienso

Meanwhile the SMC's latest round of decisions also saw it back the restricted use of Takeda's treatment for iron deficiency anaemia in chronic kidney disease (CKD) Rienso (ferumoxytol).
Orphan drug focus

318. AMAG Pharmaceuticals/ Takeda. feraheme (ferumoxytol) - for iron deficiency anaemia.
Takeda to cut 10 per cent of jobs

and Feraheme (ferumoxytol) for anaemia associated with chronic renal failure.

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest Intelligence

Interview: Trevor Smith, Takeda

iron deficiency anaemia treatment Rienso (ferumoxytol) in June.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

Spectrum appoints chief medical officer

2013. The appointment is a return to oncology for Dr Allen following a six-year spell as chief medical officer at AMAG Pharmaceuticals – the developer of Feraheme (ferumoxytol) for the treatment

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Senior External Communications Lead: £Competitive Salary

Experienced medical editor: Competitive salary and bonus scheme

Account Manager (PR): Great Benefits

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Digital Associate Director - Medcomms: £65000 - £80000 per annum

Account Director, Medical Education: Salary TBC

Account Director: £Competitive Salary

Scientific Director: £60000 - £85000 per annum, Benefits: Bonus, pension, subsidised gym and much more

Brand Manager - Medium Global Pharma Company: £Competitive Financial Package

Account director: Competitive salary and bonus scheme

Publications director: Competitive salary and bonus scheme

Account Manager: £Competitive Salary

Senior Medical Writer or Lead Medical Writer: £Competitive Salary

Account Director, Healthcare Communications: Salary TBC

Senior Medical Writer, MedComms Agency: Salary TBC

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Group Director of Medical Affairs and Scientific Strategy, Medic...: Substantial six figure package

Subscribe to our email news alerts

PMHub

Add my company

HAVAS Just::

HAVAS Just:: is a different kind of healthcare communications agency. Our mission is to create campaigns that make people think....

Latest intelligence

Novo Nordisk awakens its ‘Sleeping Beauty’: Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?: Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019: OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...